The significantly reduced incidence of sepsis development by the end of the first week in both the HR-DP and HR-CB groups compared to the HR-C group was accompanied by a significant reduction in the proinflammatory chemokine MCP-1 level within these intervention groups compared to a significant increase within the control group. This evidence concerns the gene CCL2 and Sepsis.